We would very much appreciate any thoughts you may have about OpenCME and how it could be made more useful for physicians like you.
Kim Lynch has reported having no financial arrangements or affiliations with any commercial interest(s) whose products or services may be mentioned in this activity.
Michaela Ryan, PhD
Michaela Ryan, PhD has reported having no financial arrangements or affiliations with any commercial interest(s) whose products or services may be mentioned in this activity.
This activity is co-provided by Rush University and PleXus Communications.
|Credit Type:||AMA, ANCC, CPE|
|Release Date:||February 28, 2017|
|Expiration Date:||February 27, 2018|
|Estimated Time to Complete Activity:||90 minutes|
|Fee for Activity:||None|
Summary from the 2016 Chicago Multiple Myeloma Rounds Series
To provide learners with a greater ability to formulate optimal evidence based strategies for the individualized treatment of their patients with multiple myeloma.
At the completion of the four (4) available modules, participants should be able to:
This activity is designed to meet the needs of healthcare professionals involved in the treatment of patients with multiple myeloma.
In order to receive credit for participating in this program, participants must listen to the program in its entirety and then complete and submit the CME/CE evaluation form at the conclusion of the program.
Rush University and Plexus Communications ensure balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, Rush University identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are resolved by Rush University to ensure that all scientific research referred to, reported, or used in a continuing education activity conforms to the generally accepted standards of experimental design, data collection, and analysis. Rush University is committed to providing its learners with high-quality activities that promote improvements or quality in health care and not the business interest of a commercial interest.
Rush University Medical Center is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME), to provide continuing education for the healthcare team.
Rush University Medical Center designates this enduring activity for a maximum of one and a half (1.5) AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
Rush University is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Rush University designates this enduring activity for one and a half (1.5) Continuing Education credits. This activity will fulfill Category 1 contact hour requirements for pharmacology for ANCC certified advanced practice nurses.
This program is approved for 1.5 hours (1.5 CEUs) of continuing pharmacy education credit. Proof of participation will be posted to your NABP CPE profile within 4 to 6 weeks for participants who have successfully completed the post-test. Participants must participate in the entire presentation and complete the course evaluation to receive continuing pharmacy education credit.
UPN #: 0761-9999-16-017-L01-P
Participants must complete and submit the online CE evaluation form at the conclusion of the activity and achieve a passing score of 75% or better. Certificates will be generated upon completion and submission of the evaluation form.
This activity is supported by educational grants provided by AbbVie Inc., Adaptive Biotechnologies, Celgene, Janssen Biotech, Spectrum Pharmaceuticals, and Takeda Oncology.
The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Rush University, PleXus Communications, and/or the commercial supporters. The authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Rush University, PleXus Communications and/or the commercial supporters. Rush University’s ANCC accreditation status does not imply endorsement by Rush or ANCC of any commercial products displayed in conjunction with this activity. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.
OpenCME recommends using the latest versions of these supported browsers: Google Chrome, Microsoft Internet Explorer, Mozilla Firefox, Safari. Depending on your browser of choice, additional software, such as Adobe Reader® and Adobe® Flash® Player may be required.
"OpenCME has initially been made available in a "beta" edition with minimal content, functionality and online presence. Our editorial team is working hard to add many other specialty areas to the list above."
Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.
Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.